Intrinsiqs

Is Tenaya Therapeutics, Inc. overvalued?

Tenaya Therapeutics, Inc. (TNYA) — key valuation metrics and fundamentals.

No verdict
Price
$0.73
Fair value
Current P/E
Normal P/E
Market cap
$158.0M
Dividend yield
0.0%
Return on equity
-108.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares TNYA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.